Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2013-02, Vol.160 (4), p.561-564
Hauptverfasser:	Silvennoinen, Raija, Kairisto, Veli, Pelliniemi, Tarja‐Terttu, Putkonen, Mervi, Anttila, Pekka, Säily, Marjaana, Sikiö, Anu, Opas, Jorma, Penttilä, Karri, Kuittinen, Taru, Honkanen, Tuomo, Lundán, Tuija, Juvonen, Vesa, Luukkaala, Tiina, Remes, Kari
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Boronic Acids - administration & dosage Bortezomib Combined Modality Therapy - methods Dexamethasone - administration & dosage Disease-Free Survival Hematopoietic Stem Cell Transplantation - methods Humans Middle Aged minimal residual disease molecular genetics multiple myeloma Multiple Myeloma - therapy Prospective Studies Pyrazines - administration & dosage Remission Induction stem cell transplantation1 Transplantation, Autologous Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!